Status:
UNKNOWN
Evaluation and Optimization of the Technical and Clinical Performance of the Lumenis ONE Platform
Lead Sponsor:
Rambam Health Care Campus
Collaborating Sponsors:
Lumenis Be Ltd.
Conditions:
Telangiectases
Port Wine Stain
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
The Intense Pulsed Light (IPL) technology, by selective phototermolysis, is used for eliminating, among other application, benign vascular lesions and unwanted leg veins. Light energy heats the deeper...
Detailed Description
Background: The Intense Pulsed Light (IPL) technology, by selective phototermolysis, is used for eliminating, among other application, benign vascular lesions and unwanted leg veins. Light energy hea...
Eligibility Criteria
Inclusion
- Healthy Subjects, presenting with at least one of the clinical indications mentioned above
- Willing and being able to comply with all visit and evaluation requirements
- Willing and being able to provide signed Informed Consent
Exclusion
- A history of keloid scar formation or poor wound healing
- Wounded or tanned in area to be treated
- Pregnant or intending to become pregnant during the evaluation period
- Subjects with a bleeding disorder or who take anticoagulation medications
- Significant concurrent illnesses, such as diabetes, epilepsy, lupus or congestive heart failure
- Significant concurrent skin conditions affecting area to be treated
- Having a history of skin cancer or any other cancer in the area to be treated
- History of immunosuppressive disease
Key Trial Info
Start Date :
May 1 2005
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00247299
Start Date
May 1 2005
Last Update
November 1 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Plastic surgery dept., Rambam medical center
Haifa, Israel, 9602